BB, Is there anything that the FDA could include on the label for Vascepa that would discourage insurance companies or doctors from switching scripts over from Vascepa to generic lovaza? You know a lot of ignorant doctors out there are likely telling their patients to take DS fish oil. One major challenge for AMRN is how to prevent this to begin with. Could the label for Vascepa read something like:
"Vascepa is not interchangeable for any other Omega-3 product."
Market Data 
Markets 
AI
